Cardiology

Net benefit of anticoagulants for A-fib varies with stroke rate

(HealthDay)—There is variation in the net clinical benefit of anticoagulants based on variation in published atrial fibrillation (AF) stroke rates, according to a study published online Sept. 25 in the Annals of Internal ...

Cardiology

Results from the OAC-ALONE trial reported

The first randomized trial of its kind was unable to establish non-inferiority of oral anticoagulation (OAC) alone to combined OAC and a single antiplatelet agent (APT) in patients with atrial fibrillation (AF) and stable ...

Cardiology

Extended INR test intervals safe for warfarin-treated patients

(HealthDay)—For stable warfarin-treated patients, extended international normalized ratio (INR) testing can be successfully and safely implemented, according to a study published online May 15 in the Journal of Thrombosis ...

Cardiology

Lower thromboembolic risk with new A-fib after CABG versus NVAF

(HealthDay)—For patients post coronary artery bypass graft (CABG) surgery, new-onset postoperative atrial fibrillation (POAF) is associated with lower long-term thromboembolic risk than that seen among patients with nonvalvular ...

Diseases, Conditions, Syndromes

Findings could help reduce risk of calciphylaxis in renal disease

(HealthDay)—For patients with late-stage renal disease, the presence of lupus anticoagulant and combined thrombophilias are risk factors for the development of calciphylaxis, according to a study published online Dec. 13 ...

page 8 from 23